You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Celltrion
Biotech
Genentech
Topics

Advertisement

Celltrion

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Celltrion picks AI, organoid startups for latest open innovation program Korea Biomedical Review 07:09 Wed, 10 Jun

Korea Biomedical Review 07:09 Wed, 10 Jun

Spotlight on: Biosimilar litigations - June 2026 JD Supra 17:33 Fri, 05 Jun

JD Supra 17:33 Fri, 05 Jun

Patent Law Intellectual Property

Celltrion expands Vietnam portfolio with two oncology biosimilars Korea Biomedical Review 03:34 Mon, 15 Jun

Korea Biomedical Review 03:34 Mon, 15 Jun

Advertisement

Spotlight on: Herceptin® (trastuzumab) / ogivri® (trastuzumab-dkst) / herzuma® (trastuzumab-pkrb) / ontruzant® (trastuzumab-dttb)... JD Supra 16:51 Mon, 08 Jun

JD Supra 16:51 Mon, 08 Jun

Top Tech Brands

Spotlight on: Rituxan® (rituximab) / truxima® (rituximab-abbs) / ruxience® (rituximab-pvvr) / riabni™ (rituximab-arrx) - June 2026 JD Supra 19:15 Fri, 05 Jun

JD Supra 19:15 Fri, 05 Jun

Labor disputes emerge as new risk for Samsung Biologics, Celltrion The Korea Herald 03:24 Thu, 11 Jun

The Korea Herald 03:24 Thu, 11 Jun

Consumer Electronics Pharma

Advertisement

Advertisement

Latest

In the last month

Celltrion expands Vietnam portfolio with two oncology biosimilars Korea Biomedical Review 03:34 Mon, 15 Jun

Labor disputes emerge as new risk for Samsung Biologics, Celltrion The Korea Herald 03:24 Thu, 11 Jun

Celltrion picks AI, organoid startups for latest open innovation program Korea Biomedical Review 07:09 Wed, 10 Jun

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 16:51 Mon, 08 Jun

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - June 2026 JD Supra 19:15 Fri, 05 Jun

Spotlight On: Biosimilar Litigations - June 2026 JD Supra 17:33 Fri, 05 Jun

Celltrion workers establish company's first labor union, demand compensation transparency Korea JoongAng Daily 11:05 Mon, 01 Jun

Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun

Workers at Celltrion launch first union in company's history Yonhap News Agency 06:53 Mon, 01 Jun

Celltrion develops quadruple-action obesity drug Miami Herald 12:50 Fri, 29 May

Advertisement

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna